@article{Bermudez_Jasul Jr._David-Wang_Jimeno_Magallanes_Macalalad-Josue_2018, title={Association of Metabolic Syndrome with the Severity of Airflow Obstruction in Patients with Chronic Obstructive Pulmonary Disease}, volume={33}, url={https://asean-endocrinejournal.org/index.php/JAFES/article/view/487}, abstractNote={<center><strong><img src="https://asean-endocrinejournal.org/public/site/images/admin/va-21-md.jpg" alt="" width="618" height="309"></strong></center><center><strong><img src="https://asean-endocrinejournal.org/public/site/images/admin/va-21-lay.jpg" alt="" width="618" height="309"></strong></center><center><em>*Visual Abstracts prepared by Dr. Monica Therese Cating-Cabral</em></center> <p style="text-align: justify;"><strong>Background.</strong> Metabolic Syndrome (MetS) is common in Chronic Obstructive Pulmonary Disease (COPD) patients but their association is still an unsettled issue. The aim of this study was to determine the association of MetS with the severity of airflow obstruction.</p> <p style="text-align: justify;"><strong>Methodology.</strong> This was a cross-sectional analytic study of 157 patients with COPD. They were classified using the Global Initiative for Chronic Obstructive Lung Diseases (GOLD). MetS was assessed using two well-recognized criteria. Demographics, clinical data, lifestyle-related characteristics, fasting blood sugar (FBS) and lipid profile were obtained. Multiple logistic regression was used to determine the association of MetS with the severity of airflow obstruction.</p> <p style="text-align: justify;"><strong>Results.</strong> 40.13% and 17.20% of patients had MetS using the NCEP/ATP III-AHA/NHBLI and IDF criteria, respectively. MetS was not associated with severity of airflow obstruction. Of the MetS components, only elevated blood pressure (BP) was significantly associated with severity of airflow obstruction (GOLD II: OR=3.28, p<0.001; GOLD III: OR=4.04, p=0.2; GOLD IV: OR=6.21, p=0.04). Elevated FBS was also associated with GOLD IV (OR=16.09, p=0.02). Significant factors associated with MetS in COPD patients were body mass index, inhaled steroid, number of pack-years, and GOLD II.</p> <p style="text-align: justify;"><strong>Conclusion.</strong> MetS is not associated with severity of airflow obstruction. Only certain components of MetS showed significant associations such as elevated BP with GOLD II-IV and elevated FBS with GOLD IV.</p>}, number={2}, journal={Journal of the ASEAN Federation of Endocrine Societies}, author={Bermudez, Gherald and Jasul Jr., Gabriel and David-Wang, Aileen and Jimeno, Cecilia and Magallanes, Jonray and Macalalad-Josue, Anna Angelica}, year={2018}, month={Sep.}, pages={181} }